Powell speech takes center stage in Tuesday’s economic events
Colgate Palmolive stock recently reached a 52-week low, hitting 77.05 USD. The consumer goods giant, with a market capitalization of $62.55B, maintains impressive gross profit margins of nearly 61% and demonstrates strong financial health according to InvestingPro analysis. This milestone reflects a significant downturn for the company, as it marks a substantial decline in its stock value over the past year. Over the last 12 months, Colgate Palmolive has experienced a 23.24% decrease in its stock price. Despite market pressures, the company has maintained dividend payments for 55 consecutive years and operates with relatively low price volatility, with a beta of 0.34. InvestingPro analysis suggests the stock is currently slightly undervalued, with 12 additional exclusive insights available to subscribers through their comprehensive Pro Research Report.
In other recent news, Colgate-Palmolive is preparing to announce its third-quarter earnings for 2025, with JPMorgan maintaining an Overweight rating but lowering its price target from $95.00 to $88.00 due to weaker category performance. The company continues its tradition of consistent shareholder returns, declaring a quarterly cash dividend of $0.52 per common share, payable on November 14, 2025. Morgan Stanley also adjusted its outlook, reducing its price target to $96.00 from $104.00, while maintaining an Overweight rating and expressing a mixed view on the stock’s prospects. Meanwhile, Evercore ISI reaffirmed its Outperform rating with a price target of $100.00, highlighting Colgate’s effective strategy and 2% organic sales growth despite market challenges. These developments reflect varied analyst opinions on Colgate-Palmolive’s future, with some firms expressing confidence in its strategic direction.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.